Veuillez noter que cette partie du site n’est disponible qu’en Anglais

ADR

Chr. Hansen et Novozymes ont uni leurs forces pour créer Novonesis, partenaire majeur en matière de solutions biotechnologiques. En travaillant en étroite collaboration avec nos clients, nous transformons la façon dont le monde produit et consomme dans quasiment tous les domaines.

Investisseurs | novonesis.com

 

Chr. Hansen Holding A/S has a sponsored Level 1 American Depositary Receipt (ADR) program in the US with J.P. Morgan Chase Bank N.A. acting as depositary bank.
Chr. Hansen ADRs trade in the US over-the-counter (OTC) market. From February 19, 2019 four Chr. Hansen ADRs will represent one Chr. Hansen share (4 ADRs: 1 ordinary share). 

What is an ADR?

An ADR is a USD-denominated negotiable certificate that represents ownership of shares in a non-US company. Each ADR is issued by a US depositary bank and represents one or more shares of a foreign stock or a fraction of a share. ADRs were specifically designed to facilitate the purchase, holding and sale of non-US securities by US investors.

Want to know more?

For more information please visit www.adr.com.

Partager